| Literature DB >> 35967520 |
Arpana Iyengar1, John M R Ashok1, Anil Vasudevan1.
Abstract
Introduction: Nutritional assessment in children undergoing chronic dialysis is challenging as no single objective reference tool is available. There is a need to explore the application of the subjective global nutritional assessment (SGNA) tool in these children. This study assessed the nutritional status of children on chronic dialysis using SGNA, evaluated the utility of SGNA parameters in the longitudinal assessment of nutrition, and compared the SGNA tool with other nutritional measures.Entities:
Keywords: Dialysis; SGNA; malnutrition; pediatric chronic kidney disease
Year: 2022 PMID: 35967520 PMCID: PMC9365007 DOI: 10.4103/ijn.ijn_340_21
Source DB: PubMed Journal: Indian J Nephrol ISSN: 0971-4065
Comparison of baseline parameters amongst those with and without malnutrition detected by SGNA
| Parameters | Baseline SGNA rating in CKD 5D |
| |
|---|---|---|---|
|
| |||
| Malnourished ( | Well-nourished ( | ||
| Age (months) mean±SD | 121.8±39.4 | 127.9±54 | 0.69 |
| Gender | |||
| Male | 20 | 7 | 0.85 |
| Female | 10 | 4 | |
| Duration on dialysis months [median IQR] | 9 (5,21) | 5 (2,7) | 0.054 |
| Etiology of CKD ( | |||
| Non glomerular disease | 23 (82.1%) | 5 (17.8%) | 0.057 |
| Glomerular disease | 7 (53.8%) | 6 (26.8%) | |
Association between SGNA parameters and category of nutritional status at baseline
| SGNA parameters | Well-nourished ( | Moderate malnutrition ( | Severe malnutrition ( |
|
|---|---|---|---|---|
| Height | ||||
| Normal | 9 (56) | 6 (38) | 1 (6) | 0.008 |
| Moderately less | 2 (14) | 7 (50) | 5 (36) | |
| Severely less | 0 | 6 (55) | 5 (45) | |
| Weight | ||||
| Normal | 4 (57) | 3 (43) | 0 | 0.004 |
| Moderately less | 7 (50) | 4 (29) | 3 (21) | |
| Severely less | 0 | 12 (60) | 8 (40) | |
| Change in body weight | ||||
| No change | 8 (33) | 12 (50) | 4 (17) | 0.191 |
| Improved | 3 (18) | 7 (41) | 7 (41) | |
| Worsened | 0 | 0 | 0 | |
| Diet intake | ||||
| Adequate | 9 (39) | 1252) | 2 (9) | 0.025 |
| Hypocaloric | 2 (12) | 7 (41) | 8 (47) | |
| Starvation | 0 | 0 | 1 (100) | |
| GI symptoms | ||||
| None | 11 (28) | 17 (44) | 11 (28) | 0.29 |
| Not daily | 0 | 2 (100) | 0 | |
| Daily | 0 | 0 | 0 | |
| Functional capacity | ||||
| Energetic | 10 (63) | 4 (25) | 2 (13) | 0.001 |
| Restricted | 1 (4) | 15 (63) | 8 (33) | |
| Little or no play | 0 | 0 | 1 (100) | |
| Metabolic stress | ||||
| None | 3 (60) | 2 (40) | 0 | 0.14 |
| Moderate | 8 (22) | 17 (47) | 11 (31) | |
| Severe | 0 | 0 | 0 | |
| Loss of subcutaneous fat | ||||
| Normal | 11 (58) | 7 (37) | 1 (5) | <0.001 |
| Moderate | 0 | 9 (69) | 4 (31) | |
| Severe | 0 | 3 (33) | 6 (67) | |
| Muscle Wasting | ||||
| None | 8 (62) | 4 (31) | 1 (8) | <0.001 |
| Moderate | 3 (17) | 12 (67) | 3 (17) | |
| Severe | 0 | 3 (30) | 7 (70) | |
| Oedema | ||||
| Normal | 4 (31) | 7 (54) | 2 (15) | 0.44 |
| Moderate | 7 (26) | 12 (44) | 8 (30) | |
| Severe | 0 | 0 | 1 (100) |
Figure 1SGNA categories of nutritional status at baseline and follow-up (n = 29)
Profile of individual parameters of SGNA at baseline and follow-up
| SGNA parameters ( | Baseline ( | 1st follow-up ( | 2nd follow-up ( |
|---|---|---|---|
| Height for age | |||
| Normal | 16 (39.0) | 15 (39.4) | 10 (33.3) |
| Moderately less | 14 (34.1) | 13 (34.2) | 13 (43.3) |
| Severely less | 11 (26.8) | 10 (26.3) | 7 (23.3) |
| Weight for age | |||
| Normal | 7 (17.0) | 10 (26.3) | 5 (16.6) |
| Moderately less | 14 (34.1) | 13 (34.2) | 14 (46.6) |
| Severely less | 20 (48.7) | 15 (39.4) | 11 (36.6) |
| Change in body weight | |||
| No change | 24 (58.5) | 23 (60.5) | 20 (64.5) |
| Improved | 17 (41.4) | 15 (39.4) | 11 (35.4) |
| Worsened | 0 | 0 | 0 |
| Diet intake | |||
| Adequate | 23 (56.1) | 22 (57.8) | 18 (60) |
| Hypocaloric | 17 (41.4) | 16 (42.1) | 12 (40) |
| Starvation | 1 (2.4) | 0 | 0 |
| GI symptoms | |||
| None | 39 (95.1) | 37 (97.3) | 29 (96.6) |
| Not daily | 2 (4.8) | 1 (2.6) | 1 (3.3) |
| Daily | 0 | 0 | 0 |
| Functional capacity | |||
| Energetic | 16 (39.0) | 12 (31.5) | 15 (50) |
| Restricted | 24 (58.5) | 25 (65.7) | 14 (46.6) |
| Little or no play | 1 (2.4) | 1 (2.6) | 1 (3.3) |
| Metabolic stress | |||
| None | 5 (12.2) | 7 (18.4) | 5 (16.6) |
| Moderate | 36 (87.8) | 30 (78.9) | 25 (83.3) |
| Severe | 0 | 1 (2.6) | 0 |
| Loss of subcutaneous fat | |||
| Normal | 19 (46.3) | 17 (44.7) | 11 (36.6) |
| Moderate | 13 (31.7) | 12 (31.5) | 12 (40) |
| Severe | 9 (21.9) | 9 (23.6) | 7 (23.3) |
| Muscle Wasting | |||
| None | 13 (31.7) | 12 (31.5) | 5 (16.6) |
| Moderate | 18 (43.9) | 14 (36.8) | 15 (50) |
| Severe | 10 (24.3) | 12 (31.5) | 10 (33.3) |
| Oedema | |||
| Normal | 13 (31.7) | 10 (26.3) | 6 (20) |
| Moderate | 27 (65.8) | 28 (73.6) | 23 (76.6) |
| Severe | 1 (2.4) | 0 | 1 (3.3) |